Segulah

Segulah Medical Acceleration (SMA) is a specialized investment company focused on the Nordic life science and medical technology sectors. Established in 2020, the firm targets growth-stage companies with innovative products in areas such as diagnostics, medical devices, and life science tools. SMA provides strategic capital and hands-on support to help its portfolio companies scale internationally and navigate complex regulatory environments. The firm's investment strategy emphasizes businesses with strong intellectual property and the potential for significant international expansion. By bridging the gap between early-stage venture capital and traditional private equity, SMA plays a critical role in the Scandinavian healthcare ecosystem.